HepatoScore-14: Measures of biological heterogeneity significantly improve prediction of hepatocellular carcinoma risk

BACKGROUND & AIMS: Therapeutic, clinical trial entry and stratification decisions for hepatocellular carcinoma (HCC) are made based on prognostic assessments, using clinical staging systems based on small numbers of empirically selected variables that insufficiently account for differences in bi...

詳細記述

保存先:
書誌詳細
出版年:Hepatology
主要な著者: Morris, Jeffrey S., Hassan, Manal M., Zohner, Ye Emma, Wang, Zeya, Xiao, Lianchun, Rashid, Asif, Haque, Abedul, Abdel-Wahab, Reham, Mohamed, Yehia A., Ballard, Karri L., Wolff, Robert A., George, Bhawana, Li, Liang, Allen, Genevera, Weylandt, Michael, Li, Donghui, Wang, Wenyi, Raghav, Kanwal, Yao, James, Amin, Hesham M., Kaseb, Ahmed Omar
フォーマット: Artigo
言語:Inglês
出版事項: 2021
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7956911/
https://ncbi.nlm.nih.gov/pubmed/32931023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.31555
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料